Lv11
30 积分 2022-07-19 加入
Advances in Ovarian Cancer Care and Unmet Treatment Needs for Patients With Platinum Resistance
11小时前
待确认
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
2天前
已完结
Efficacy and safety of efdamrofusp alfa versus aflibercept in participants with neovascular age-related macular degeneration: a randomized, double-masked, active-controlled, non-inferiority, phase 2 trial
2个月前
已完结
Efficacy and Safety of Brolucizumab for Diabetic Macular Edema
3个月前
已完结
Faricimab: First Approval
3个月前
已完结
A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration
4个月前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
4个月前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
4个月前
已完结
VP4-2024: First-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients (pts) with advanced solid tumors: First-in-human phase I study
4个月前
已完结
Age-related macular degeneration
4个月前
已完结
皖公网安备34019202002308
